Cytotoxic anticancer agents and renal impairment study: the challenge remains
- PMID: 16391294
- DOI: 10.1200/JCO.2005.03.8299
Cytotoxic anticancer agents and renal impairment study: the challenge remains
Comment in
-
Design, conduct, and interpretation of organ impairment studies in oncology patients.J Clin Oncol. 2006 Jul 20;24(21):3509-10; author reply 3510-1. doi: 10.1200/JCO.2006.06.6795. J Clin Oncol. 2006. PMID: 16849773 No abstract available.
Comment on
-
Phase I and pharmacokinetic study of pemetrexed administered every 3 weeks to advanced cancer patients with normal and impaired renal function.J Clin Oncol. 2006 Feb 1;24(4):552-62. doi: 10.1200/JCO.2004.00.9720. Epub 2006 Jan 3. J Clin Oncol. 2006. PMID: 16391300 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
